Compare ARK Genomic Revolution ETF (ARKG) vs Cintas Corporation (CTAS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Cintas Corporation — how do they compare? ARK Genomic Revolution ETF trades at $44.88, while Cintas Corporation trades at $205.28 (market cap $82.15B). The key difference: Cintas Corporation pays a 1.01% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Cintas Corporation nearer its low. Which is the better fit depends on your goals.
| ARKG | CTAS | |
|---|---|---|
Sector | Sector/Thematic | Industrials |
52-Week High | $44.55 | $225.10 |
52-Week Low | $24.02 | $163.55 |
Market Cap | — | $82.15B |
Enterprise Value | — | $84.56B |
Dividend Yield | — | 1.01% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Cintas Corporation
In its core uniform and facility services unit (78% of sales), Cintas provides uniform rental programs to businesses across the size spectrum, mostly in North America. The firm is by far the largest provider in the industry. Facilities products generally include the rental and sale of entrance mat, mops, shop towels, hand sanitizers, and restroom supplies. Cintas also runs a first aid and safety services business (11% of sales), a fire protection services business (7% of sales), and a uniform direct sales business (4% of sales).
Read more on CTAS →
